Globeflex Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,531
Closed -$269K 504
2022
Q3
$269K Hold
1,531
0.05% 328
2022
Q2
$308K Hold
1,531
0.08% 283
2022
Q1
$347K Hold
1,531
0.07% 291
2021
Q4
$413K Hold
1,531
0.08% 272
2021
Q3
$370K Hold
1,531
0.08% 264
2021
Q2
$363K Buy
+1,531
New +$349K 0.07% 322
2017
Q3
Sell
-17,754
Closed -$2.35M 412
2017
Q2
$2.35M Buy
17,754
+1,938
+12% +$237K 0.58% 27
2017
Q1
$1.95M Sell
15,816
-134
-0.8% -$15.9K 0.46% 43
2016
Q4
$1.76M Buy
15,950
+1,476
+10% +$164K 0.44% 39
2016
Q3
$1.71M Sell
14,474
-275
-2% -$32.4K 0.43% 49
2016
Q2
$1.65M Buy
14,749
+862
+6% +$92.8K 0.45% 48
2016
Q1
$1.4M Sell
13,887
-112
-0.8% -$10.7K 0.37% 64
2015
Q4
$1.49M Buy
13,999
+22
+0.2% +$2.27K 0.4% 54
2015
Q3
$1.3M Sell
13,977
-2,991
-18% -$309K 0.28% 102
2015
Q2
$1.77M Buy
16,968
+3,977
+31% +$414K 0.32% 78
2015
Q1
$1.41M Buy
+12,991
New +$1.34M 0.27% 129

Other funds holding LH

Globeflex Capital's LH Position: Q4 2022 in Review

Globeflex Capital sold out of Labcorp (LH) in Q4 2022, closing a stake of 1,531 shares — an estimated $269K sold.

Globeflex Capital first reported a position in LH in Q1 2015 and held it in 16 quarters. The position peaked at $2.35M in Q2 2017. 971 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • Globeflex Capital reported no remaining Labcorp position as of Q4 2022 after selling out during the quarter.
  • Globeflex Capital sold 1,531 Labcorp shares in Q4 2022, an estimated $269K.
  • Globeflex Capital first reported a position in Labcorp in Q1 2015 and held it in 16 quarters.
  • Globeflex Capital's Labcorp position peaked at $2.35M in Q2 2017.
  • 971 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Globeflex Capital's 13F filing for Q4 2022, filed 10 Feb 2023.